RE:RE:RE:RE:Good luck this week my fellow long shareholdersDavidRosenberg wrote: GrahamB wrote: Thanks for the kind words Mil man.
To the point |David, here are the key questions that may be of interest to those consiodering a purchase of FSD:
So Lucid is partly owned by Durkacz and so its a related party transaction, meaning he benefited from FSD purchasing LUCID ?
What was the value of Lucid BEFORE FSD bought them for 11 million ?(ie-perhaps the value during the most recent financing)
How much did the LUCID owners benefit from the buyout by the premium paid by FSD?
Was there a transaction cost billed to FSD by First republic?
What is the molecule?
(Is this a psilocybin generic-so back to the cannabis story again-commodity and ADs "race to the bopttom"?
What/where is the evidence of preclinical or clinical efficaCY OF THE MYSTERY MOLECULES being promoted fopr depresssion and MS?
why don't you contact Anthony for the lucid transaction details ?
as for the molecule I am also interested to see where does it stand , I would also like to see some evidence of efficacy but it's a NCE right ? The value lies with UHN doing 10 years of research on the molecule how would that translate into benefiting shareholders remains to be seen we need to see hard proof that it works I agree with you and milman on that point ...
adurkacz@fsdpharma.com Here is his email feel free to ask him instead of me about the business transaction between lucid and fsd etc
translation: "it isnt in my talking points I was provided and it isnt in any of the youtube videos I post, so I have idea."
probably why he is dodging the shareholder value question ...